XML 76 R45.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Significant Operating Segment Revenue and Expenses, and Operating Segment Adjusted EBITDA

The following table presents significant operating segment revenue and expenses, and Operating Segment Adjusted EBITDA:

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

Net revenues:

 

 

 

 

 

 

 

 

 

Admissions

 

$

883,385

 

 

$

939,629

 

 

$

954,083

 

Food, merchandise and other

 

 

779,174

 

 

 

785,672

 

 

 

772,504

 

Total revenues

 

 

1,662,559

 

 

 

1,725,301

 

 

 

1,726,587

 

Segment costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of food, merchandise and other revenues

 

 

127,553

 

 

 

130,573

 

 

 

131,059

 

Operating labor-related expenses

 

 

398,632

 

 

 

381,523

 

 

 

384,870

 

Other operating expenses

 

 

255,965

 

 

 

252,131

 

 

 

248,940

 

Marketing expenses

 

 

121,360

 

 

 

114,553

 

 

 

104,569

 

Other segment items

 

 

49,319

 

 

 

42,933

 

 

 

43,436

 

Operating Segment Adjusted EBITDA

 

$

709,730

 

 

$

803,588

 

 

$

813,713

 

Other expenses(a)

 

 

(174,579

)

 

 

(176,923

)

 

 

(199,732

)

Provision for income taxes

 

 

(58,184

)

 

 

(64,029

)

 

 

(78,911

)

Loss on early extinguishment of debt and write-off of discounts and debt issuance costs

 

 

 

 

 

(3,939

)

 

 

 

Interest expense

 

 

(134,140

)

 

 

(167,762

)

 

 

(146,666

)

Depreciation and amortization

 

 

(174,474

)

 

 

(163,438

)

 

 

(154,208

)

Net Income

 

$

168,353

 

 

$

227,497

 

 

$

234,196

 

(a)
Other expenses represent costs not allocated to the operating segments including (i) general and administrative expenses, (ii) equity-based compensation expense, (iii) certain non-cash charges/credits including those related to asset disposals and self-insurance reserve adjustments, (iv) certain business optimization, development and strategic initiative costs, (v) merger, acquisition, integration and certain investment costs, and (vi) other nonrecurring costs including incremental costs associated with the COVID-19 pandemic or similar unusual events.